146 related articles for article (PubMed ID: 8201832)
1. Value of serum and effusion fluid CEA levels for distinguishing between diffuse malignant mesothelioma and carcinomatous pleural metastases.
Mezger J; Calavrezos A; Drings P; Gatzemeier U; Kaukel E; Konietzko N; Koschel G; Lamerz R; von Pawel J; Römer W
Lung; 1994; 172(3):183-4. PubMed ID: 8201832
[No Abstract] [Full Text] [Related]
2. Diagnostic value of CYFRA 21-1 tumor marker and CEA in pleural effusion due to mesothelioma.
Paganuzzi M; Onetto M; Marroni P; Filiberti R; Tassara E; Parodi S; Felletti R
Chest; 2001 Apr; 119(4):1138-42. PubMed ID: 11296181
[TBL] [Abstract][Full Text] [Related]
3. Lung surfactant protein-A and carcinoembryonic antigen in pleural effusions due to lung adenocarcinoma and malignant mesothelioma.
Shijubo N; Honda Y; Fujishima T; Takahashi H; Kodama T; Kuroki Y; Akino T; Abe S
Eur Respir J; 1995 Mar; 8(3):403-6. PubMed ID: 7789485
[TBL] [Abstract][Full Text] [Related]
4. [Diagnostic value of the combined determination of carcinoembryonic antigen (CEA) in pleural effusion and serum with an enzyme immunoassay (EIA). Sensitivity, specificity and relation to tumor type].
Klech H; Rona G; Hutter C; Bayer PM; Kummer F
Wien Klin Wochenschr; 1986 Sep; 98(17):564-73. PubMed ID: 3020811
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic significance of carcinoembryonic antigen in the differential diagnosis of malignant mesothelioma.
Mezger J; Lamerz R; Permanetter W
J Thorac Cardiovasc Surg; 1990 Dec; 100(6):860-6. PubMed ID: 2147220
[TBL] [Abstract][Full Text] [Related]
6. Utility of hyaluronic acid in pleural fluid for differential diagnosis of pleural effusions: likelihood ratios for malignant mesothelioma.
Atagi S; Ogawara M; Kawahara M; Sakatani M; Furuse K; Ueda E; Yamamoto S
Jpn J Clin Oncol; 1997 Oct; 27(5):293-7. PubMed ID: 9390204
[TBL] [Abstract][Full Text] [Related]
7. Improvement of the diagnosis of the cause of pleural effusion in patients with lung cancer by simultaneous quantification of carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) pleural levels.
Menard O; Dousset B; Jacob C; Martinet Y
Eur J Cancer; 1993; 29A(13):1806-9. PubMed ID: 8260229
[TBL] [Abstract][Full Text] [Related]
8. Concentration of hyaluronic acid in pleural fluid as a diagnostic aid for malignant mesothelioma.
Pettersson T; Fröseth B; Riska H; Klockars M
Chest; 1988 Nov; 94(5):1037-9. PubMed ID: 3180855
[TBL] [Abstract][Full Text] [Related]
9. Use of tumor markers for differential diagnosis of mesothelioma and secondary pleural malignancies.
Fuhrman C; Duche JC; Chouaid C; Abd Alsamad I; Atassi K; Monnet I; Tillement JP; Housset B
Clin Biochem; 2000 Jul; 33(5):405-10. PubMed ID: 11018693
[TBL] [Abstract][Full Text] [Related]
10. [Carcinoembryonic antigen in serum and pleural fluid to distinguish between bronchial carcinoma and pleural mesothelioma].
Mezger J; Lamerz R; Bresgen M; Schulz A; Berghäuser KH; Liewald F; Sunder-Plassmann L; Häussinger K; Wilmanns W
Dtsch Med Wochenschr; 1991 Feb; 116(6):207-11. PubMed ID: 1993432
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic value of CA 72-4, carcinoembryonic antigen, CA 15-3, and CA 19-9 assay in pleural fluid. A study of 207 patients.
Villena V; López-Encuentra A; Echave-Sustaeta J; Martín-Escribano P; Ortuño-de-Solo B; Estenoz-Alfaro J
Cancer; 1996 Aug; 78(4):736-40. PubMed ID: 8756365
[TBL] [Abstract][Full Text] [Related]
12. Pleural to serum CEA ratio in lung adenocarcinoma.
Satoh H; Ishikawa H; Yamashita YT; Ohtsuka M; Sekizawa K
Clin Oncol (R Coll Radiol); 2002 Apr; 14(2):178-9. PubMed ID: 12069128
[No Abstract] [Full Text] [Related]
13. Detection of tissue CEA-like substance as an aid in the differential diagnosis of malignant mesothelioma.
Whitaker D; Sterrett GF; Shilkin KB
Pathology; 1982 Jul; 14(3):255-8. PubMed ID: 6290965
[TBL] [Abstract][Full Text] [Related]
14. Immunocytochemical characterization of malignant mesothelioma and carcinoma metastatic to the pleura: IOB3--a new tumor marker.
Kortsik CS; Werner P; Freudenberg N; Virchow JC; Kroegel C; Pott M; Matthys H
Lung; 1995; 173(2):79-87. PubMed ID: 7536281
[TBL] [Abstract][Full Text] [Related]
15. Carcinoembryonic antigen in pleural effusions. Diagnostic value in malignant mesothelioma.
Faravelli B; D'Amore E; Nosenzo M; Betta PG; Donna A
Cancer; 1984 Mar; 53(5):1194-7. PubMed ID: 6362839
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical panel for distinction between squamous cell carcinoma, adenocarcinoma and mesothelioma.
Pritchard SA; Howat AJ; Edwards JM
Histopathology; 2003 Aug; 43(2):197-9. PubMed ID: 12877739
[No Abstract] [Full Text] [Related]
17. Diagnostic efficacy of electron microscopy and pleural effusion cytology for the distinction of pleural mesothelioma and lung adenocarcinoma.
Domínguez-Malagón H; Cano-Valdez AM; González-Carrillo C; Campos-Salgado YE; Lara-Garcia A; Lopez-Mejia M; Corona-Cruz JF; Arrieta O
Ultrastruct Pathol; 2016; 40(5):254-60. PubMed ID: 27405014
[TBL] [Abstract][Full Text] [Related]
18. Vimentin, carcinoembryonic antigen and keratin in the diagnosis of mesothelioma, adenocarcinoma and reactive pleural lesions.
al-Saffar N; Hasleton PS
Eur Respir J; 1990 Oct; 3(9):997-1001. PubMed ID: 1705232
[TBL] [Abstract][Full Text] [Related]
19. [Malignant diffuse pleural mesothelioma confirming diagnosis].
Calavrezos A; Hain E
Dtsch Med Wochenschr; 1982 Jun; 107(23):903-6. PubMed ID: 7084057
[No Abstract] [Full Text] [Related]
20. [Diagnostic contribution of the determination of CEA, pH, glucose and lactase dehydrogenase in the pleural fluid in patients with mesothelioma].
Rapellino M; Borasio P; Baldi S; Coni F; Oliaro A; Libertucci D; Ardissone F
Minerva Med; 1987 Mar; 78(5):317-9. PubMed ID: 3822223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
